Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Common Equity (2016 - 2025)

China Pharma Holdings filings provide 16 years of Common Equity readings, the most recent being $22.7 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 193.5% to $22.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.7 million, a 193.5% increase, with the full-year FY2025 number at $22.7 million, up 193.5% from a year prior.
  • Common Equity hit $22.7 million in Q4 2025 for China Pharma Holdings, up from $8.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $22.7 million in Q4 2025 to a low of $2.8 million in Q3 2022.
  • Median Common Equity over the past 5 years was $6.5 million (2021), compared with a mean of $7.0 million.
  • Biggest five-year swings in Common Equity: crashed 58.64% in 2022 and later surged 193.5% in 2025.
  • China Pharma Holdings' Common Equity stood at $6.0 million in 2021, then dropped by 28.71% to $4.3 million in 2022, then surged by 73.77% to $7.5 million in 2023, then grew by 3.93% to $7.7 million in 2024, then surged by 193.5% to $22.7 million in 2025.
  • The last three reported values for Common Equity were $22.7 million (Q4 2025), $8.3 million (Q3 2025), and $6.5 million (Q2 2025) per Business Quant data.